High-dose leucovorin as sole therapy for methotrexate toxicity.
about
Clinical review: specific aspects of acute renal failure in cancer patientsSelective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcuminSuspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancyResumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients.Chiral toxicology: it's the same thing...only different.Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicityGlucarpidase following high-dose methotrexate: update on development.Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department.Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.Regulation of T cell proliferation with drug-responsive microRNA switches.Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: influence of nutritional folate status on toxicity.Guidelines for treatment of renal injury during cancer chemotherapy 2016.Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma
P2860
Q28217608-C4D6BEEE-0D27-4D45-9D00-B50AF5950914Q28478523-D1C8AC93-9B35-42D6-99C5-CF08F48CDAE7Q33401038-1EF88838-4DE5-4B74-A333-465BEB74ECA0Q33402976-89981083-07AD-463C-A644-74A5CC097A3AQ34247793-646A15B4-EB0A-4014-9510-41D4AC858669Q34979115-0BF62711-7F00-4234-A179-CF6795F0FC2DQ36548685-7AB2ECF7-F4B0-4BD4-8705-880BA5F85B76Q37446958-DE86ED9E-3683-4BFB-9FD0-28B10650F4F2Q37635158-4B0E7230-9512-4AC7-835A-D10029D665BEQ38543699-BA4AD8DB-E88F-4D61-A3D8-19D0830EE590Q42220380-4C3BD4A5-82A3-48D0-9CAD-59AD21F7AB63Q43260573-934A6C74-18CA-4CF4-AAA5-C1DCF27501EEQ45950927-CF7F44CD-FCBC-4FA4-84B7-3BE3CEB54888Q46446111-921DAE91-25C1-480A-B4F2-3B81FCE0C849Q46784423-A01CC1F8-ACD4-4ADC-9A8C-63F00AD5DD4EQ50063006-00FC443C-909D-4440-A5A8-802547642E71Q58764411-795B35C0-B5EC-40F3-8067-3868F1908F39
P2860
High-dose leucovorin as sole therapy for methotrexate toxicity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
High-dose leucovorin as sole therapy for methotrexate toxicity.
@ast
High-dose leucovorin as sole therapy for methotrexate toxicity.
@en
High-dose leucovorin as sole therapy for methotrexate toxicity.
@nl
type
label
High-dose leucovorin as sole therapy for methotrexate toxicity.
@ast
High-dose leucovorin as sole therapy for methotrexate toxicity.
@en
High-dose leucovorin as sole therapy for methotrexate toxicity.
@nl
prefLabel
High-dose leucovorin as sole therapy for methotrexate toxicity.
@ast
High-dose leucovorin as sole therapy for methotrexate toxicity.
@en
High-dose leucovorin as sole therapy for methotrexate toxicity.
@nl
P1476
High-dose leucovorin as sole therapy for methotrexate toxicity.
@en
P2093
C D Flombaum
P A Meyers
P304
P356
10.1200/JCO.1999.17.5.1589
P407
P577
1999-05-01T00:00:00Z